Gender-affirming hormone therapy: Difference between revisions

Content deleted Content added
Masculinizing hormone therapy: small corrections/clarifications to roi
Line 90:
{{main|Masculinizing hormone therapy}}
 
[[Masculinizing hormone therapy]] is typically used by transgender men, who desire the development of masculine secondary sex characteristics. Masculinizing hormone therapy usually includes [[testosterone (medication)|testosterone]] to produce [[masculinization]] and suppress the production of [[estrogen]].<ref>{{Cite web|url=https://www.mayoclinic.org/tests-procedures/ftm-hormone-therapy/about/pac-20385099|title=Masculinizing hormone therapy - Mayo Clinic|website=www.mayoclinic.org|access-date=2019-08-02|archive-date=2019-07-16|archive-url=https://web.archive.org/web/20190716035520/https://www.mayoclinic.org/tests-procedures/ftm-hormone-therapy/about/pac-20385099|url-status=live}}</ref> Treatment options include [[oral administration|oral]], [[Subcutaneous administration|subcutaneous injections]] or [[subcutaneous implant|implant]], and [[transdermal administration|transdermal]] ([[transdermal patch|patches]], [[transdermal gel|gel]]s). Dosing is patient-specific, depending on the patient's rate of [[metabolism]], and is discussed with the physician.<ref name="Transgender_Care_Testosterone">{{Cite web|url=https://transcare.ucsf.edu/article/information-testosterone-hormone-therapy|title=Information on Testosterone Hormone Therapy|work=Transgender Care|publisher=transcare.ucsf.edu|access-date=2019-08-07|archive-date=2019-11-22|archive-url=https://web.archive.org/web/20191122161637/https://transcare.ucsf.edu/article/information-testosterone-hormone-therapy|url-status=live}}</ref> The most commonly prescribed methods are [[intramuscular injection|intramuscular]] and [[subcutaneous injection]]s.{{Citation needed|date=August 2024}} This dosing can be daily, weekly or biweekly depending on the [[route of administration]] and the individual patient.<ref name="Transgender_Care_Testosterone" />
 
Unlike feminizing hormone therapy, individuals undergoing masculinizing hormone therapy do not usually require additional hormone suppression such as estrogen suppression. Therapeutic doses of testosterone are usually sufficient to inhibit the production of estrogen to desired physiologic levels.<ref name="Bangalore_Krishna_2019" />
Line 118:
|Breast atrophy
|-
|Increased RBCred blood cell count
|
|}